Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Jun 15;99(12):2961–2970. doi: 10.1172/JCI119491

Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells.

T Ishizuya 1, S Yokose 1, M Hori 1, T Noda 1, T Suda 1, S Yoshiki 1, A Yamaguchi 1
PMCID: PMC508148  PMID: 9185520

Abstract

It has been reported that PTH exerts bone-forming effects in vivo when administered intermittently. In the present study, the anabolic effects of PTH(1-34) on osteoblast differentiation were examined in vitro. Osteoblastic cells isolated from newborn rat calvaria were cyclically treated with PTH(1-34) for the first few hours of each 48-h incubation cycle. When osteoblastic cells were intermittently exposed to PTH only for the first hour of each 48-h incubation cycle and cultured for the remainder of the cycle without the hormone, osteoblast differentiation was inhibited by suppressing alkaline phosphatase activity, bone nodule formation, and mRNA expression of alkaline phosphatase, osteocalcin, and PTH/PTHrP receptor. Experiments using inhibitors and stimulators of cAMP/protein kinase A (PKA) and Ca2+/PKC demonstrated that cAMP/PKA was the major signal transduction system in the inhibitory action of PTH. In contrast, the intermittent exposure to PTH for the first 6 h of each 48-h cycle stimulated osteoblast differentiation. Both cAMP/ PKA and Ca2+/PKC systems appeared to be involved cooperatively in this anabolic effect. Continuous exposure to PTH during the 48-h incubation cycle strongly inhibited osteoblast differentiation. Although both cAMP/PKA and Ca2+/PKC were involved in the effect of continuous exposure to PTH, they appeared to act independently. A neutralizing antibody against IGF-I blocked the stimulatory effect on alkaline phosphatase activity and the expression of osteocalcin mRNA induced by the 6-h intermittent exposure. The inhibitory effect induced by the 1-h intermittent exposure was not affected by anti-IGF-I antibody. These results suggest that PTH has diverse effects on osteoblast differentiation depending on the exposure time in vitro mediated through different signal transduction systems. These in vitro findings explain at least in part the in vivo action of PTH that varies with the mode of administration.

Full Text

The Full Text of this article is available as a PDF (490.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bellows C. G., Aubin J. E., Heersche J. N., Antosz M. E. Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int. 1986 Mar;38(3):143–154. doi: 10.1007/BF02556874. [DOI] [PubMed] [Google Scholar]
  2. Bellows C. G., Ishida H., Aubin J. E., Heersche J. N. Parathyroid hormone reversibly suppresses the differentiation of osteoprogenitor cells into functional osteoblasts. Endocrinology. 1990 Dec;127(6):3111–3116. doi: 10.1210/endo-127-6-3111. [DOI] [PubMed] [Google Scholar]
  3. Canalis E., Centrella M., Burch W., McCarthy T. L. Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures. J Clin Invest. 1989 Jan;83(1):60–65. doi: 10.1172/JCI113885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dobnig H., Turner R. T. Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology. 1995 Aug;136(8):3632–3638. doi: 10.1210/endo.136.8.7628403. [DOI] [PubMed] [Google Scholar]
  5. Friedman P. A., Coutermarsh B. A., Kennedy S. M., Gesek F. A. Parathyroid hormone stimulation of calcium transport is mediated by dual signaling mechanisms involving protein kinase A and protein kinase C. Endocrinology. 1996 Jan;137(1):13–20. doi: 10.1210/endo.137.1.8536604. [DOI] [PubMed] [Google Scholar]
  6. Fukayama S., Schipani E., Jüppner H., Lanske B., Kronenberg H. M., Abou-Samra A. B., Bringhurst F. R. Role of protein kinase-A in homologous down-regulation of parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acid in human osteoblast-like SaOS-2 cells. Endocrinology. 1994 Apr;134(4):1851–1858. doi: 10.1210/endo.134.4.8137752. [DOI] [PubMed] [Google Scholar]
  7. Hock J. M., Centrella M., Canalis E. Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology. 1988 Jan;122(1):254–260. doi: 10.1210/endo-122-1-254. [DOI] [PubMed] [Google Scholar]
  8. Hori M., Uzawa T., Morita K., Noda T., Takahashi H., Inoue J. Effect of human parathyroid hormone (PTH(1-34)) on experimental osteopenia of rats induced by ovariectomy. Bone Miner. 1988 Jan;3(3):193–199. [PubMed] [Google Scholar]
  9. Isogai Y., Akatsu T., Ishizuya T., Yamaguchi A., Hori M., Takahashi N., Suda T. Parathyroid hormone regulates osteoblast differentiation positively or negatively depending on the differentiation stages. J Bone Miner Res. 1996 Oct;11(10):1384–1393. doi: 10.1002/jbmr.5650111003. [DOI] [PubMed] [Google Scholar]
  10. Jongen J. W., Bos M. P., van der Meer J. M., Herrmann-Erlee M. P. Parathyroid hormone-induced changes in alkaline phosphatase expression in fetal calvarial osteoblasts: differences between rat and mouse. J Cell Physiol. 1993 Apr;155(1):36–43. doi: 10.1002/jcp.1041550106. [DOI] [PubMed] [Google Scholar]
  11. Kano J., Sugimoto T., Fukase M., Chihara K. Cross talk of dual-signal transduction systems in the regulation of DNA synthesis by parathyroid hormone in osteoblastic osteosarcoma cells. J Bone Miner Res. 1993 Mar;8(3):323–329. doi: 10.1002/jbmr.5650080309. [DOI] [PubMed] [Google Scholar]
  12. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., Rosen V., Wozney J. M., Fujisawa-Sehara A., Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol. 1994 Dec;127(6 Pt 1):1755–1766. doi: 10.1083/jcb.127.6.1755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lee K., Deeds J. D., Bond A. T., Jüppner H., Abou-Samra A. B., Segre G. V. In situ localization of PTH/PTHrP receptor mRNA in the bone of fetal and young rats. Bone. 1993 May-Jun;14(3):341–345. doi: 10.1016/8756-3282(93)90162-4. [DOI] [PubMed] [Google Scholar]
  14. Lee K., Deeds J. D., Chiba S., Un-No M., Bond A. T., Segre G. V. Parathyroid hormone induces sequential c-fos expression in bone cells in vivo: in situ localization of its receptor and c-fos messenger ribonucleic acids. Endocrinology. 1994 Jan;134(1):441–450. doi: 10.1210/endo.134.1.8275957. [DOI] [PubMed] [Google Scholar]
  15. Linkhart T. A., Mohan S. Parathyroid hormone stimulates release of insulin-like growth factor-I (IGF-I) and IGF-II from neonatal mouse calvaria in organ culture. Endocrinology. 1989 Sep;125(3):1484–1491. doi: 10.1210/endo-125-3-1484. [DOI] [PubMed] [Google Scholar]
  16. MacDonald B. R., Gallagher J. A., Russell R. G. Parathyroid hormone stimulates the proliferation of cells derived from human bone. Endocrinology. 1986 Jun;118(6):2445–2449. doi: 10.1210/endo-118-6-2445. [DOI] [PubMed] [Google Scholar]
  17. Majeska R. J., Rodan G. A. Alkaline phosphatase inhibition by parathyroid hormone and isoproterenol in a clonal rat osteosarcoma cell line. Possible mediation by cyclic AMP. Calcif Tissue Int. 1982 Jan;34(1):59–66. doi: 10.1007/BF02411210. [DOI] [PubMed] [Google Scholar]
  18. Majeska R. J., Rodan S. B., Rodan G. A. Maintenance of parathyroid hormone response in clonal rat osteosarcoma lines. Exp Cell Res. 1978 Feb;111(2):465–468. doi: 10.1016/0014-4827(78)90193-3. [DOI] [PubMed] [Google Scholar]
  19. McCarthy T. L., Centrella M., Canalis E. Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone. Endocrinology. 1989 Mar;124(3):1247–1253. doi: 10.1210/endo-124-3-1247. [DOI] [PubMed] [Google Scholar]
  20. Meng X. W., Liang X. G., Birchman R., Wu D. D., Dempster D. W., Lindsay R., Shen V. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats. J Bone Miner Res. 1996 Apr;11(4):421–429. doi: 10.1002/jbmr.5650110402. [DOI] [PubMed] [Google Scholar]
  21. Nakatani Y., Tsunoi M., Hakeda Y., Kurihara N., Fujita K., Kumegawa M. Effects of parathyroid hormone on cAMP production and alkaline phosphatase activity in osteoblastic clone MC3T3-E1 cells. Biochem Biophys Res Commun. 1984 Sep 28;123(3):894–898. doi: 10.1016/s0006-291x(84)80219-3. [DOI] [PubMed] [Google Scholar]
  22. Nishida S., Yamaguchi A., Tanizawa T., Endo N., Mashiba T., Uchiyama Y., Suda T., Yoshiki S., Takahashi H. E. Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow. Bone. 1994 Nov-Dec;15(6):717–723. doi: 10.1016/8756-3282(94)90322-0. [DOI] [PubMed] [Google Scholar]
  23. Partridge N. C., Alcorn D., Michelangeli V. P., Kemp B. E., Ryan G. B., Martin T. J. Functional properties of hormonally responsive cultured normal and malignant rat osteoblastic cells. Endocrinology. 1981 Jan;108(1):213–219. doi: 10.1210/endo-108-1-213. [DOI] [PubMed] [Google Scholar]
  24. Partridge N. C., Opie A. L., Opie R. T., Martin T. J. Inhibitory effects of parathyroid hormone on growth of osteogenic sarcoma cells. Calcif Tissue Int. 1985 Sep;37(5):519–525. doi: 10.1007/BF02557835. [DOI] [PubMed] [Google Scholar]
  25. Pfeilschifter J., Laukhuf F., Müller-Beckmann B., Blum W. F., Pfister T., Ziegler R. Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone. J Clin Invest. 1995 Aug;96(2):767–774. doi: 10.1172/JCI118121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Podbesek R., Edouard C., Meunier P. J., Parsons J. A., Reeve J., Stevenson R. W., Zanelli J. M. Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds. Endocrinology. 1983 Mar;112(3):1000–1006. doi: 10.1210/endo-112-3-1000. [DOI] [PubMed] [Google Scholar]
  27. Reeve J., Hesp R., Williams D., Hulme P., Klenerman L., Zanelli J. M., Darby A. J., Tregear G. W., Parsons J. A. Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis. Lancet. 1976 May 15;1(7968):1035–1038. doi: 10.1016/s0140-6736(76)92216-9. [DOI] [PubMed] [Google Scholar]
  28. Scutt A., Duvos C., Lauber J., Mayer H. Time-dependent effects of parathyroid hormone and prostaglandin E2 on DNA synthesis by periosteal cells from embryonic chick calvaria. Calcif Tissue Int. 1994 Sep;55(3):208–215. doi: 10.1007/BF00425877. [DOI] [PubMed] [Google Scholar]
  29. Stein G. S., van Wijnen A. J., Stein J. L., Lian J. B., Bidwell J. P., Montecino M. Nuclear architecture supports integration of physiological regulatory signals for transcription of cell growth and tissue-specific genes during osteoblast differentiation. J Cell Biochem. 1994 May;55(1):4–15. doi: 10.1002/jcb.240550103. [DOI] [PubMed] [Google Scholar]
  30. Sudo H., Kodama H. A., Amagai Y., Yamamoto S., Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol. 1983 Jan;96(1):191–198. doi: 10.1083/jcb.96.1.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sugimoto T., Ikeda K., Kano J., Yamaguchi T., Fukase M., Chihara K. Cross-talk of parathyroid hormone-responsive dual signal transduction systems in osteoblastic osteosarcoma cells: its role in PTH-induced homologous desensitization of intracellular calcium response. J Cell Physiol. 1994 Feb;158(2):374–380. doi: 10.1002/jcp.1041580220. [DOI] [PubMed] [Google Scholar]
  32. Tam C. S., Heersche J. N., Murray T. M., Parsons J. A. Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration. Endocrinology. 1982 Feb;110(2):506–512. doi: 10.1210/endo-110-2-506. [DOI] [PubMed] [Google Scholar]
  33. Terakado A., Tagawa M., Goto S., Yamazaki M., Moriya H., Fujimura S. Elevation of alkaline phosphatase activity induced by parathyroid hormone in osteoblast-like cells from the spinal hyperostotic mouse TWY (twy/twy). Calcif Tissue Int. 1995 Feb;56(2):135–139. doi: 10.1007/BF00296345. [DOI] [PubMed] [Google Scholar]
  34. Turksen K., Grigoriadis A. E., Heersche J. N., Aubin J. E. Forskolin has biphasic effects on osteoprogenitor cell differentiation in vitro. J Cell Physiol. 1990 Jan;142(1):61–69. doi: 10.1002/jcp.1041420109. [DOI] [PubMed] [Google Scholar]
  35. Uzawa T., Hori M., Ejiri S., Ozawa H. Comparison of the effects of intermittent and continuous administration of human parathyroid hormone(1-34) on rat bone. Bone. 1995 Apr;16(4):477–484. doi: 10.1016/8756-3282(95)90194-9. [DOI] [PubMed] [Google Scholar]
  36. Watson P., Lazowski D., Han V., Fraher L., Steer B., Hodsman A. Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats. Bone. 1995 Mar;16(3):357–365. doi: 10.1016/8756-3282(94)00051-4. [DOI] [PubMed] [Google Scholar]
  37. Wronski T. J., Yen C. F. Anabolic effects of parathyroid hormone on cortical bone in ovariectomized rats. Bone. 1994 Jan-Feb;15(1):51–58. doi: 10.1016/8756-3282(94)90891-5. [DOI] [PubMed] [Google Scholar]
  38. Wronski T. J., Yen C. F., Qi H., Dann L. M. Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats. Endocrinology. 1993 Feb;132(2):823–831. doi: 10.1210/endo.132.2.8425497. [DOI] [PubMed] [Google Scholar]
  39. Yamaguchi A., Kahn A. J. Clonal osteogenic cell lines express myogenic and adipocytic developmental potential. Calcif Tissue Int. 1991 Sep;49(3):221–225. doi: 10.1007/BF02556122. [DOI] [PubMed] [Google Scholar]
  40. Yamamoto I., Shigeno C., Potts J. T., Jr, Segre G. V. Characterization and agonist-induced down-regulation of parathyroid hormone receptors in clonal rat osteosarcoma cells. Endocrinology. 1988 Apr;122(4):1208–1217. doi: 10.1210/endo-122-4-1208. [DOI] [PubMed] [Google Scholar]
  41. Yokose S., Ishizuya T., Ikeda T., Nakamura T., Tsurukami H., Kawasaki K., Suda T., Yoshiki S., Yamaguchi A. An estrogen deficiency caused by ovariectomy increases plasma levels of systemic factors that stimulate proliferation and differentiation of osteoblasts in rats. Endocrinology. 1996 Feb;137(2):469–478. doi: 10.1210/endo.137.2.8593791. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES